Welch Allyn launches Class I recall
This article was originally published in The Silver Sheet
Welch Allyn has recalled 1,794 AED 10 automated external defibrillators because of a possibility that the devices may fail to deliver appropriate shocks for resuscitation. AED 10s manufactured at the firm's Beaverton, Ore., facility between March 29, 2007, and Aug. 9, 2007, may contain defective capacitors affecting a patient's ECG reading. The firm, which launched the recall Oct. 26, says no adverse events have occurred as a result of the error. The Class I recall comes on the heels of the firm's Aug. 24 Class I recall of its AED 20 automated external defibrillators, and previous Class I recalls for the AED 20 in June 2006 and May 2005
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.